N-(biphenyl-4-ylmethyl)-3-(methoxymethyl)-1H-indole-2-sulfonamide

ID: ALA4513527

PubChem CID: 66546714

Max Phase: Preclinical

Molecular Formula: C23H22N2O3S

Molecular Weight: 406.51

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COCc1c(S(=O)(=O)NCc2ccc(-c3ccccc3)cc2)[nH]c2ccccc12

Standard InChI:  InChI=1S/C23H22N2O3S/c1-28-16-21-20-9-5-6-10-22(20)25-23(21)29(26,27)24-15-17-11-13-19(14-12-17)18-7-3-2-4-8-18/h2-14,24-25H,15-16H2,1H3

Standard InChI Key:  DZDVZXNVKSJSHQ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   34.3839   -2.6951    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3881   -3.5123    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   35.0937   -3.1001    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.8909   -3.1201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.8897   -3.9397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5978   -4.3486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5960   -2.7113    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3046   -3.1165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3094   -3.9397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0938   -4.1895    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.5738   -3.5207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0860   -2.8577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8038   -4.2212    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.6209   -4.2163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0337   -4.9216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6283   -5.6301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.0404   -6.3349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8585   -6.3306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2627   -5.6155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8483   -4.9136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2729   -7.0328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8677   -7.7438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2808   -8.4480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0988   -8.4425    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.5021   -7.7269    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0867   -7.0256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3340   -2.0790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.1323   -1.9044    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.3802   -1.1277    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
 12  8  1  0
 11  2  1  0
  2 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 18 21  1  0
 12 27  1  0
 27 28  1  0
 28 29  1  0
M  END

Associated Targets(Human)

CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 406.51Molecular Weight (Monoisotopic): 406.1351AlogP: 4.46#Rotatable Bonds: 7
Polar Surface Area: 71.19Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.21CX Basic pKa: CX LogP: 4.24CX LogD: 4.23
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.48Np Likeness Score: -0.68

References

1. Greig IR, Baillie GL, Abdelrahman M, Trembleau L, Ross RA..  (2016)  Development of indole sulfonamides as cannabinoid receptor negative allosteric modulators.,  26  (18): [PMID:27542310] [10.1016/j.bmcl.2016.08.018]

Source